candles form a ribbon on World AIDS Day 2014 in South Sudan.
UNAIDS
in a widely expected move, the World Health Organization (WHO) today approved antiretroviral (ARV) treatment for 37 million people infected with HIV worldwide. previous guidelines called for only treat the estimated 28 million people infected with HIV who have fewer than 500 CD4 cells per microlitre of blood. (The normal range is 0 to 10.) The new guidelines also call for providing the drugs to prevent pre-exposure prophylaxis to infection called HIV, or PrEP to all persons to "substantial risk" infection.
Currently, only 15 million people infected with HIV received antiretrovirals. But in rich countries, it is becoming increasingly common to start early treatment before the CD4 cells from a patient had significant declines. Large studies have shown that early treatment benefits for people infected with HIV and, separately, that ARVs significantly reduce the risk of transmission. Several similar PrEP studies have shown that ARVs protect uninfected people regardless of the transmission path.
The Joint United Nations Programme on HIV / AIDS previously called for "fast-track" approach to end the World AIDS epidemic in 2030 that would increase investments now needed annually to $ 21.7 billion by $ 12 billion . Accelerated target only call 81% of people infected with HIV to be on ARVs by 2020. There remains a huge question mark if the world is going to pay for these ambitious goals. This will require more domestic spending by low-income countries which are hardest hit by the epidemic, and the great contributions of rich countries.
WHO called the new recommendations of a "release early guidelines" and plans to release more comprehensive revisions in 2016. WHO has begun to publish HIV treatment guidelines in 02, how ARVs are recommended only for people who had less than 0 CD4.
0 Komentar